Assenagon Asset Management S.A. Lowers Position in Soleno Therapeutics, Inc. $SLNO
Assenagon Asset Management S.A. lowered its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 42.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The in…